Startseite Clinical follow-up data and the rate of development of precocious and rapidly progressive puberty in patients with premature thelarche
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Clinical follow-up data and the rate of development of precocious and rapidly progressive puberty in patients with premature thelarche

  • Dilek Çiçek , Senay Savas-Erdeve EMAIL logo , Semra Cetinkaya und Zehra Aycan
Veröffentlicht/Copyright: 26. Januar 2018

Abstract

Background:

We aimed to evaluate the clinical follow-up data of patients with premature thelarche and determine the rate of development of precocious and early puberty in these patients.

Methods:

The charts of 158 girls with premature thelarche who were followed-up in our pediatric endocrinology polyclinic were reviewed. The patients were divided into three groups according to the age at onset: group 1 (0–1 month) (n=12), group 2 (1–24 months) (n=40) and group 3 (2–8 years) (n=106).

Results:

At admission, the mean height standard deviation score (SDS), body weight (BW)-SDS, body mass index (BMI) and BMI-SDS were significantly higher in group 3 than in group 1 and group 2. At admission, 8.8% of the patients were obese and 24% of the patients were overweight. The majority of patients who were obese and overweight were in group 3. At the end of the follow-up, thelarche regressed in 24.7%, persisted in 32.9%, progressed in 25.9% and had a cyclic pattern in 16.5% of the patients. Precocious or rapidly progressive puberty developed in 47 of the 158 patients (29.7%). The mean age at progression to early or rapidly progressive puberty was 98.1±17.6 months. A total of 89.3% of the patients who progressed to early or rapidly progressive puberty were in group 3.

Conclusions:

Precocious or rapidly progressive puberty developed in 29.7% of subjects with premature thelarche. As patients who developed rapidly progressive puberty had a higher BW-SDS and BMI-SDS than those who did not, it is suggested that the increase in weight could stimulate rapidly progressive puberty in cases with premature thelarche.


Corresponding author: Senay Savas-Erdeve, MD, Associate Professor, Dr. Sami Ulus Obstetrics and Gynecology, Children’s Health and Disease Training and Research Hospital, Pediatric Endocrinology Department, Plevne Mahallesi, Babür Caddesi, No:36-38 (06080) Altındağ, Ankara, Turkey, Phone: +90 (312) 305 65 39, Fax: +90 (312) 317 03 53

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Atay Z, Turan S, Guran T, Furman A, Bereket A. The prevalence and risk factors of premature thelarche and pubarche in 4- to 8-year-old girls. Acta Pædiatrica 2012;101:71–5.10.1111/j.1651-2227.2011.02444.xSuche in Google Scholar

2. Van Winter JT, Noller KL, Zimmerman D, Melton LJ. III. Natural history of premature thelarche in Olmsted County, Minnesota, 1940 to 1984. J Pediatr 1990;116:278–80.10.1016/S0022-3476(05)82891-4Suche in Google Scholar

3. Pasquino AM, Pucarelli I, Passeri F, Segni M, Mancini MA, et al. Progression of premature thelarche to central precocious puberty. J Pediatr 1995;126:11–4.10.1016/S0022-3476(95)70492-2Suche in Google Scholar

4. Volta C, Bernasconi S, Cisternino M, Buzi F, Ferzetti A, et al. Isolated premature thelarche and thelarche variant: clinical and auxiological follow-up of 119 girls. J Endocrinol Invest 1998;21:180–3.10.1007/BF03347298Suche in Google Scholar PubMed

5. Verrotti A, Ferrari M, Morgese G, Charelli F. Premature thelarche: a long-term follow-up. Gynecol Endocrinol 1996;10:241–7.10.3109/09513599609012315Suche in Google Scholar PubMed

6. Stanhope R. Premature thelarche: clinical follow-up and indication for treatment. J Pediatr Endocrinol Metab 2000;13:827–30.10.1515/JPEM.2000.13.S1.827Suche in Google Scholar

7. Pasquino AM, Tebaldi L, Cioschi L, Cives C, Finocchi G, et al. Premature thelarche: a follow-up study of 40 girls. Arch Dis Child 1985;60:1180–2.10.1136/adc.60.12.1180Suche in Google Scholar PubMed PubMed Central

8. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, et al. Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006;95:1635–41.10.1080/08035250600652013Suche in Google Scholar PubMed

9. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, et al. Body mass index references for Turkish children. Acta Paediatr 2006;95:194–8.10.1080/08035250500334738Suche in Google Scholar PubMed

10. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.10.1136/adc.44.235.291Suche in Google Scholar PubMed PubMed Central

11. Neely EK, Hintz RL, Wilson DM, Lee PA, Gautier T, et al. Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr 1995;127:40–6.10.1016/S0022-3476(95)70254-7Suche in Google Scholar

12. Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, et al. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metabol 1999;84:3575–8.10.1210/jcem.84.10.6032Suche in Google Scholar PubMed

13. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. Stanford, California: Standford University Press, 1959.10.1097/00000441-195909000-00030Suche in Google Scholar

14. De Vries L, Guz-Mark A, Lazar L, Reches A, Phillip M. Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty. J Pediatr 2010;156:466–71.10.1016/j.jpeds.2009.09.071Suche in Google Scholar PubMed

15. Rosenfield RL, Burstein S, Cuttler L, Cara JF, Levitsky LL, et al. Use of nafarelin for testing pituitary-ovarian function. J Reprod Med 1989;34:1044–50.Suche in Google Scholar

16. Chellakooty M, Schmidt IM, Haavisto AM, Boisen KA, Damgaard IN, et al. Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab 2003;88:3515–20.10.1210/jc.2002-021468Suche in Google Scholar PubMed

17. Borges MF, Pacheco KD, Oliveria AA, Rita CV, Pacheco KD, et al. Premature thelarche: clinical and laboratorial assessment by immunochemiluminescent assay. Arq Bras Endocrinol Metab 2008;52/1:93–100.10.1590/S0004-27302008000100013Suche in Google Scholar PubMed

18. Bizzarri C, Spadoni GL, Bottaro G, Montanari G, Giannone G, et al. The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of prematüre thelarche in the first 3 years of life. J Clin Endocrinol Metab 2014;99:433–9.10.1210/jc.2013-3292Suche in Google Scholar PubMed

19. Tenore A, Franzese A, Quattrin T, Sandomenico ML, Aloi G, et al. Prognostic signs in the evolution of premature thelarche by discriminant analysis. J Endocrinol Invest 1991;14:375–81.10.1007/BF03349086Suche in Google Scholar PubMed

20. Uçar A, Saka N, Baş F, Bundak R, Günöz H, et al. Is premature thelarche in the first 2 years of life transient? J Clin Res Pediatr Endocrinol 2012;4:140–5.10.4274/Jcrpe.709Suche in Google Scholar PubMed PubMed Central

21. Çatlı G, Erdem P, Anık A, Abacı A, Böber E. Clinical and laboratory findings in the differential diagnosis of central precocious puberty and premature thelarche. Turk Ars Pediatr 2015;50:20–6.10.5152/tpa.2015.2281Suche in Google Scholar PubMed PubMed Central

22. Della Manna T, Setian N, Damiani D, Kuperman H, Dichtchekenian V. Premature thelarche: identification of clinical and laboratory data for the diagnosis of precocious puberty. Rev Hosp Clin Fac Med Sao Paulo 2002;57:49–54.10.1590/S0041-87812002000200001Suche in Google Scholar

23. Ilicki A, Prager Lewin R, Kauli R, Haufman H, Schachter A, et al. Premature thelarche-natural history and sex hormone secretion in 68 girls. Acta Paediatr Scand 1984;73:756.10.1111/j.1651-2227.1984.tb17771.xSuche in Google Scholar PubMed

Received: 2017-6-24
Accepted: 2017-12-22
Published Online: 2018-1-26
Published in Print: 2018-3-28

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Vitamin D deficiency in childhood: old lessons and current challenges
  4. Original Articles
  5. Brain gray matter volume differences in obese youth with type 2 diabetes: a pilot study
  6. Prevalence and clinical presentation at the onset of type 1 diabetes mellitus among children and adolescents in AL-Baha region, Saudi Arabia
  7. Whole blood viscosity and cerebral blood flow velocities in obese hypertensive or obese normotensive adolescents
  8. The utility of body mass index as an indicator for lipid abnormalities in non-fasting children
  9. Association of insulin-like growth factor-1 and IGF binding protein-3 with 25-hydroxy vitamin D in pre-pubertal and adolescent Indian girls
  10. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study
  11. Clinical follow-up data and the rate of development of precocious and rapidly progressive puberty in patients with premature thelarche
  12. Age of pubertal events among school girls in Lagos, Nigeria
  13. Evaluation of basal sex hormone levels for activation of the hypothalamic–pituitary–gonadal axis
  14. PHKG2 mutation spectrum in glycogen storage disease type IXc: a case report and review of the literature
  15. Twenty-seven mutations with three novel pathologenic variants causing biotinidase deficiency: a report of 203 patients from the southeastern part of Turkey
  16. Case Reports
  17. Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation
  18. A rare unbalanced Y:autosome translocation in a Turner syndrome patient
  19. A Japanese patient with congenital central hypothyroidism caused by a novel IGSF1 mutation
  20. Growth, sexual and bone development in a boy with bilateral anorchia under testosterone treatment guided by the development of his monozygotic twin
Heruntergeladen am 23.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0247/html
Button zum nach oben scrollen